These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30876979)

  • 1. BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling.
    Song H; Shi L; Xu Y; Xu T; Fan R; Cao M; Xu W; Song J
    Eur J Pharmacol; 2019 Jun; 852():189-197. PubMed ID: 30876979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRD4 promotes glioma cell stemness via enhancing miR-142-5p-mediated activation of Wnt/β-catenin signaling.
    Wang J; Quan Y; Lv J; Gong S; Dong D
    Environ Toxicol; 2020 Mar; 35(3):368-376. PubMed ID: 31724259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limonin attenuates the stemness of breast cancer cells via suppressing MIR216A methylation.
    Su Z; Wang C; Chang D; Zhu X; Sai C; Pei J
    Biomed Pharmacother; 2019 Apr; 112():108699. PubMed ID: 30970511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-324-3p promotes gastric cancer development by activating Smad4-mediated Wnt/beta-catenin signaling pathway.
    Sun GL; Li Z; Wang WZ; Chen Z; Zhang L; Li Q; Wei S; Li BW; Xu JH; Chen L; He ZY; Ying K; Zhang X; Xu H; Zhang DC; Xu ZK
    J Gastroenterol; 2018 Jun; 53(6):725-739. PubMed ID: 29103082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
    Fan D; Ren B; Yang X; Liu J; Zhang Z
    J Exp Clin Cancer Res; 2016 Nov; 35(1):177. PubMed ID: 27846906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-216a-3p promotes differentiation of BMMSCs into ACE II cells via Wnt/β-catenin pathway.
    Song H; Lu HN; Chen X; Jiang XF; Yang Y; Feng J
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7849-7857. PubMed ID: 30536330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway.
    Yang XZ; Cheng TT; He QJ; Lei ZY; Chi J; Tang Z; Liao QX; Zhang H; Zeng LS; Cui SZ
    Mol Cancer; 2018 Aug; 17(1):126. PubMed ID: 30134915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer.
    Zheng JJ; Que QY; Xu HT; Luo DS; Sun Z; Ni JS; Que HF; Ma J; Wu D; Shi H
    Technol Cancer Res Treat; 2020; 19():1533033820905825. PubMed ID: 32216582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile.
    Dong L; Deng J; Sun ZM; Pan AP; Xiang XJ; Zhang L; Yu F; Chen J; Sun Z; Feng M; Xiong JP
    Tumour Biol; 2015 Sep; 36(9):6973-83. PubMed ID: 25861021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling.
    Liang J; Liu Y; Zhang L; Tan J; Li E; Li F
    Chem Biol Interact; 2019 May; 304():1-9. PubMed ID: 30831090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-216a-3p Inhibits the Proliferation, Migration, and Invasion of Human Gastric Cancer Cells via Targeting RUNX1 and Activating the NF-κB Signaling Pathway.
    Wu Y; Zhang J; Zheng Y; Ma C; Liu XE; Sun X
    Oncol Res; 2018 Jan; 26(1):157-171. PubMed ID: 28835317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-216a-3p inhibits osteogenic differentiation of human adipose-derived stem cells via Wnt3a in the Wnt/β-catenin signaling pathway.
    Liang D; Song G; Zhang Z
    Exp Ther Med; 2022 Apr; 23(4):309. PubMed ID: 35340869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ZFAS1 regulates the malignant progression of gastric cancer via the microRNA-200b-3p/Wnt1 axis.
    Zhang F; Li Y; Xu W; He L; Tan Y; Xu H
    Biosci Biotechnol Biochem; 2019 Jul; 83(7):1289-1299. PubMed ID: 30999814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-532 promoted gastric cancer migration and invasion by targeting NKD1.
    Hu S; Zheng Q; Wu H; Wang C; Liu T; Zhou W
    Life Sci; 2017 May; 177():15-19. PubMed ID: 28356225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/β-catenin signalling.
    Yuan J; Tan L; Yin Z; Zhu W; Tao K; Wang G; Shi W; Gao J
    Cell Death Dis; 2019 Jun; 10(6):454. PubMed ID: 31186404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-590-3p promotes colon cancer cell proliferation via Wnt/β-catenin signaling pathway by inhibiting WIF1 and DKK1.
    Feng ZY; Xu XH; Cen DZ; Luo CY; Wu SB
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4844-4852. PubMed ID: 29164578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.